Motif Bio Announces New Iclaprim Data being Presented at ECCMID 2018

    NEXT STORY
    Oasmia has completed a private placement of new convertible instruments in a total amount of SEK 26,000,000
    PREV STORY
    Novartis appoints John Tsai Head of Global Drug Development and Chief Medical Officer
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Physicians Dialysis Acquires Seven Dialysis Facilities in New Jersey and Texas

    MIAMI, May 04, 2017 (GLOBE NEWSWIRE) -- Physicians Dialysis today announced that it has ...

    author_avatar
    NASDAQ Market News

    Trishula Therapeutics Appoints Anil Singhal as Chief Executive Officer

    author_avatar
    NASDAQ Market News

    Global PoC Molecular Diagnostic Market is estimated to be US$ 6.7 Billion by 2029 with a CAGR of 14.8% during the Forecast Period – PMI

    author_avatar
    NASDAQ Market News